Ifosfamide, carboplatin, and etoposide in combination for induction and high-dose chemotherapy: focus on breast cancer and lymphoma

Hematol Oncol. 1992 Jan-Feb;10(1):61-74. doi: 10.1002/hon.2900100111.
No abstract available

Publication types

  • Clinical Trial
  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / toxicity
  • Breast Neoplasms / drug therapy*
  • Carboplatin / administration & dosage*
  • Dose-Response Relationship, Drug
  • Etoposide / administration & dosage*
  • Female
  • Hematopoiesis / drug effects
  • Humans
  • Ifosfamide / administration & dosage*
  • Lymphoma / drug therapy*
  • Male
  • Survival Analysis

Substances

  • Etoposide
  • Carboplatin
  • Ifosfamide